Reported Oct 3, 2012 · Terminated
NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by
Glenmark Generics Inc., USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Glenmark Generics Inc., USA · 750 Corporate Dr · Mahwah, NJ · 07430-2009
Is this the product you have?
NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India |
| 2 | Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430 |
| 3 | NDC 68462-190-01. |
- Lot codes and dates
Lot #: 021129300211293402112941Exp 09/1421129850211298602113334Exp 10/14021133600211337202113420021136060211366302113664Exp 11/14
- Amount recalled
- unknown
Where it was sold
- Nationwide
Why it was recalled
Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Glenmark Generics Inc., USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.